“…The effect of dexmedetomidine in I/R models depends on several factors, such as the route of administration (intravenous (39), intraperitoneal (12,19), dosage, type of ischemic tissue or organ, duration and temperature of ischemia, timing of administration (before (12,19,22) or after (18) ischemia) and the species itself.…”